Clinical Forums Recaps

A major challenge addressed in the Clinical Forum was managing BCG shortages and the implications for patient care.

This Clinical Forum event provided a comprehensive overview of the current landscape in treating NMIBC.

The Clinical Forum underscored the importance of clinical trials and multidisciplinary collaboration in advancing bladder cancer care.

"When we select abiraterone for our patients with mHSPC, there's a choice between generic and branded options," says Paul C. Dato MD.

A recent Urology Times Clinical Forum provided an in-depth overview of current and emerging strategies for managing NMIBC.

A pair of roundtable discussions encompassed a range of topics related to UTUC, including clinical guidelines, treatment considerations, and patient cases.

Two recent Clinical Forum discussions sought to examine how emerging therapeutic options and evolving treatment standards in non–muscle invasive bladder cancer affect clinical practices and patient outcomes.

Three recent expert-led Clinical Forums explored current challenges and advancements in the management of non–muscle invasive bladder cancer.

In 2 recent case-based roundtable discussions, experts tackled diagnosis and treatment strategy for upper tract urothelial carcinoma.

Two recent roundtable discussions focused on the challenges and evolving treatment strategies in upper tract urothelial carcinoma.

Two case-based roundtable discussions recently covered the advancing of care for patients with low-grade upper tract urothelial carcinoma.